CLSI M39

Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data, 5th Edition

This guideline describes methods for recording and analyzing antimicrobial susceptibility test data, consisting of cumulative and ongoing summaries of susceptibility patterns of clinically significant microorganisms.

More Details

Member price:

List Price:

Details

Chairholder: Janet A. Hindler, MCLS, MT(ASCP), F(AAM); Patricia J. Simner, PhD, D(ABMM)

Date of Publication: January 24, 2022

Order Code PDF: CLSI M39Ed5E
ISBN Number: 978-1-68440-133-8

Order Code Print: CLSI M39Ed5
ISBN Number: 978-1-68440-132-1

Edition: Fifth

Pages: 192

CLSI M39 Additional Details

A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.

CLSI M39 Abstract

Susceptibility statistical data, consisting of the cumulative and ongoing summary of the antimicrobial susceptibility patterns of clinically important microorganisms, are important to the practice of medicine on several levels. If the methods used to create, record, and analyze the data are not reliable and consistent, many of the most important applications and benefits of the data will not be realized. Clinical and Laboratory Standards Institute document M39—Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data provides guidelines for medical laboratories and data analysis software providers for the routine generation and storage of susceptibility data and for the compilation of susceptibility statistics. This guideline also provides suggestions for medical laboratories, clinicians, and others involved in antimicrobial stewardship on effective use of their cumulative susceptibility statistics when empirical antimicrobial therapy is selected.